Carsten Boltze - Concepedia

Author

Carsten Boltze

Otto-von-Guericke University Magdeburg

Also Known As

C BOLTZE, C Boltze, C. Boltze, C. Boltze, Carsten Boltze, G. Heil

118

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

Otto-von-Guericke University Magdeburg University Hospital Magdeburg University of Rostock SRH Wald-Klinikum Gera Leipzig University

About

Carsten Boltze is an author at Otto-von-Guericke University Magdeburg specializing in medicine, pathology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	38	2.3K
2	Cell Biology	17	18	1.2K
3	Engineering	2	2	90
4	Health Sciences	1	1	27
5	Natural Sciences	1	1	35

Carsten Boltze

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism. Hala Gali‐Muhtasib, Mona Diab‐Assaf, Carsten Boltze, Chemoprevention StrategyApoptosisCell DeathPathologyCell Cycle	2004	293
Solitary Fibrous Tumors/Hemangiopericytomas with Different Variants of the NAB2-STAT6 Gene Fusion Are Characterized by Specific Histomorphology and Distinct Clinicopathological Features Sarah Barthelmeß, Helene Geddert, Carsten Boltze, American Journal Of Pathology Tumoral PathologySurgical PathologyPathologySpecific HistomorphologySolitary Fibrous Tumors/hemangiopericytomas	2014	231
Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism. Hala Gali‐Muhtasib, Mona Diab‐Assaf, Carsten Boltze, PubMed Chemoprevention StrategyApoptosisCell DeathPathologyCell Cycle	2004	191
High Prognostic Value of p16<sup><i>INK4</i></sup> Alterations in Gastrointestinal Stromal Tumors Regine Schneider‐Stock, Carsten Boltze, Jerzy Lasota, Journal of Clinical Oncology	2003	147
Expression and Regulation of CD97 in Colorectal Carcinoma Cell Lines and Tumor Tissues Matthias Steinert, Manja Wobus, Carsten Boltze, American Journal Of Pathology Tumor BiologyMedicineColorectal CancerTumor SuppressorTumor Tissues	2002	135
Loss of p16 Protein Defines High-Risk Patients with Gastrointestinal Stromal Tumors: A Tissue Microarray Study Regine Schneider‐Stock, Carsten Boltze, Jerzy Lasota, Clinical Cancer Research P16 LossImmunologyGastroenterologyPathologyGastric Tumors	2005	119
RETRACTION: 5-aza-Cytidine Is a Potent Inhibitor of DNA Methyltransferase 3a and Induces Apoptosis in HCT-116 Colon Cancer Cells via Gadd45- and p53-Dependent Mechanisms Regine Schneider‐Stock, Mona Diab-Assef, Astrid Rohrbeck, Journal of Pharmacology and Experimental Therapeutics	2005	112
Gastrointestinal Stromal Tumors with Internal Tandem Duplications in 3′ End of KIT Juxtamembrane Domain Occur Predominantly in Stomach and Generally Seem to Have a Favorable Course Jerzy Lasota, Agnieszka Dansonka‐Mieszkowska, Tomasz Stachura, Modern Pathology Gastrointestinal OncologySurgical PathologyGastroenterologyPathologyGastrointestinal Stromal Tumors	2003	109
CD97, but Not Its Closely Related EGF-TM7 Family Member EMR2, Is Expressed on Gastric, Pancreatic, and Esophageal Carcinomas Gabriela Aust, Matthias Steinert, Alexander Schütz, American Journal of Clinical Pathology	2002	96
KIT 1530ins6 mutation defines a subset of predominantly malignant gastrointestinal stromal tumors of intestinal origin1 1The opinions and assertions contained herein are the expressed views of the authors and are not to be construed as official or reflecting the views of the Departments of the Army or Defense. Jerzy Lasota, Janusz Kopczyński, Maarit Sarlomo‐Rikala, Human Pathology OncologySomatic VariantGastrointestinal OncologyMedicineGenetics	2003	86

Page 1